Trial Details

COMPLETED
Basic Information
Clinical ID c4502
Identifier NCT00417391
Trial Title Phase II Study of RR110 in Patients With Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions DRUG: RR110 (Tamibarotene)|DRUG: RR110 (Tamibarotene)
Participant Information
Sponsor R&R Inc.
City Aichi-ken
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2006-12
Primary Completion Date 2008-05
Completion Date 2008-05